Literature DB >> 3136588

Irreversible interstitial pneumonitis associated with tocainide therapy.

B Van Natta, M Lazarus, C Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136588      PMCID: PMC1026263     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  5 in total

1.  Tocainide-associated interstitial pneumonitis.

Authors:  G M Perlow; B P Jain; S G Pauker; H S Zarren; D C Wistran; R L Epstein
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

2.  Tocainide-associated interstitial pneumonitis.

Authors:  A C Braude; E Downar; D W Chamberlain; A S Rebuck
Journal:  Thorax       Date:  1982-04       Impact factor: 9.139

Review 3.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-03

Review 4.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-02

5.  Safety evaluation of tocainide in the American Emergency Use Program.

Authors:  H R Horn; Z Hadidian; J L Johnson; H G Vassallo; J H Williams; M D Young
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

  5 in total
  1 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.